GlobeNewswire 01.10 Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
GlobeNewswire 01.10 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders
GlobeNewswire 29.09 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholde...
GlobeNewswire 29.09 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic ...
GlobeNewswire 29.09 Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
GlobeNewswire 24.09 New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral d...
GlobeNewswire 23.09 Major Shareholder Announcement
GlobeNewswire 23.09 BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
GlobeNewswire 11.09 Scancell reports Business Update and Financial Results for the Year Ended 30 April 2025
GlobeNewswire 08.09 First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A B...
GlobeNewswire 27.08 Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals ...
GlobeNewswire 22.08 Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biop...
GlobeNewswire 19.08 SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
GlobeNewswire 14.08 Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 07.08 Genmab Announces Financial Results for the First Half of 2025
GlobeNewswire 07.08 Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Rel...
GlobeNewswire 04.08 BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
GlobeNewswire 25.07 Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the Europea...
GlobeNewswire 22.07 Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Imm...
GlobeNewswire 21.07 BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
GlobeNewswire 17.07 BioNTech Announces Ryan Richardson to Step Down from the Management Board
GlobeNewswire 16.07 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025
GlobeNewswire 01.07 Genmab Announces Changes to its Executive Committee
GlobeNewswire 12.06 BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
GlobeNewswire 02.06 BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commerc...